Improving Patient Care with Anh Nguyen _ e.064


Episode Artwork
1.0x
0% played 00:00 00:00
Feb 25 2025 48 mins   1

Dr. Anh Nguyen has built a career at the intersection of medicine, biotechnology, and public policy, bringing a unique perspective on how scientific innovation translates into real-world impact. As the co-founder and CEO of Alnair Therapeutics, Anh is leading the development of a novel drug delivery platform designed to transform cancer treatment, ensuring that therapies reach their targets more effectively while reducing side effects for patients. 

In this episode of Lab Rats to Unicorns, Anh shares his journey from clinical practice to biotech entrepreneurship, detailing the pivotal moments that led him to launch and lead innovative startups. He also reflects on his time working within the FDA and CMS, offering insider insights into the regulatory landscape and how policies like the 21st Century Cures Act shape the future of drug development. 

Beyond biotech, Anh discusses the parallels between endurance sports—he's completed multiple Ironman triathlons—and the perseverance required to navigate the highs and lows of building a biotech company.  

Whether you’re an entrepreneur, a scientist, or just fascinated by the future of medicine, this conversation dives deep into the challenges, breakthroughs, and leadership lessons that define the evolving world of life sciences. Tune in for an inspiring discussion on resilience, innovation, and the drive to improve patient care through cutting-edge science and strategic execution.